公开(公告)号：US09706770B2

公开(公告)日：2017-07-18

申请号：US15318195

申请日：2015-06-11

申请人： LIPHATECH ,  VETAGRO SUP

发明人： Herve Caruel ,  Bernadette Espana ,  Stephane Besse ,  Virginie Lattard ,  Etienne Benoit

IPC分类号： A01N43/16 ,  C07D311/56 ,  A01N25/00 ,  A23K50/50 ,  A23K10/30

CPC分类号： A01N25/004 ,  A01N43/16 ,  A23K10/30 ,  A23K50/50

摘要： Disclosed is a rodenticide bait including: difenacoum in the form of trans-difenacoum of formula 3-(biphenyl-4-yl)-1 -(4-hydroxycoumarin-3-yl)-1,2,3,4-tetrahydronaphthalene, in wherein carbons 1 and 3 of group 1,2,3,4-tetrahydronaphthalene of the trans-difenacoum have the same absolute configuration; and an edible excipient for target rodent pests. The bait includes trans-difenacoum at a concentration above a minimum trans-difenacoum concentration lethal to female adults of the target rodents, but below a minimum trans-difenacoum concentration lethal to adult males of the target rodents, the minimum concentration lethal to female adults being less than the minimum concentration lethal to male adults. Also disclosed is a method for selectively controlling a population of target rodent pests.

公开(公告)号：US20240041812A1

公开(公告)日：2024-02-08

申请号：US18235533

申请日：2023-08-18

申请人： SOCIÉTÉ DES PRODUITS NESTLÉ S.A. ,  BAYLOR COLLEGE OF MEDICINE

发明人： Stephen Kirnon ,  Eric Freedland ,  Rajagopal V. Sekhar

IPC分类号： A61K31/198 ,  A61K38/05 ,  A61K31/167 ,  A61K31/223 ,  A61K31/341 ,  A61K38/21 ,  A61K31/683 ,  A61K31/27 ,  A61K45/06 ,  A61K31/381 ,  A61K31/205 ,  A61P39/06 ,  A23K20/142 ,  A23K50/50 ,  A61P21/00 ,  A61P39/00 ,  A61P31/18 ,  A61P29/00 ,  A61K38/02

CPC分类号： A61K31/198 ,  A61K38/05 ,  A61K31/167 ,  A61K31/223 ,  A61K31/341 ,  A61K38/21 ,  A61K31/683 ,  A61K31/27 ,  A61K45/06 ,  A61K31/381 ,  A61K31/205 ,  A61P39/06 ,  A23K20/142 ,  A23K50/50 ,  A61P21/00 ,  A61P39/00 ,  A61P31/18 ,  A61P29/00 ,  A61K38/02

摘要： Compositions and methods are related to utilizing glycine and N-acetylcysteine for a variety of medical conditions related to reduced levels of glycine, N-acetylcysteine, and/or glutathione, for example, muscle loss such as sarcopenia, HIV infection and other infections, organ damage such as those from diabetes and insulin resistance and diabetic nephropathy, cardiac function and failure such as preventing or improving heart failure, fatty liver, cancer prevention, and other conditions.

公开(公告)号：US11779032B2

公开(公告)日：2023-10-10

申请号：US16931227

申请日：2020-07-16

申请人： International Dehydrated Foods, Inc.

发明人： Roger Lynn Dake ,  Stephanie Lynch ,  Rodney McFadden

IPC分类号： A23J3/04 ,  A23L2/66 ,  A23K50/80 ,  A23K10/20 ,  A23K50/70 ,  A23K50/75 ,  A23K50/42 ,  A23K40/10 ,  A23K40/00 ,  A23K50/50 ,  A23L33/17

CPC分类号： A23J3/04 ,  A23K10/20 ,  A23K40/00 ,  A23K40/10 ,  A23K50/42 ,  A23K50/50 ,  A23K50/70 ,  A23K50/75 ,  A23K50/80 ,  A23L2/66 ,  A23L33/17

摘要： This disclosure provides a highly concentrated protein composition and the processes of making the same. The compositions are shelf-stable, easy to use and have excellent nutritional values as compared to other protein products. The compositions may be prepared from animal sources, such as chickens or turkeys.

公开(公告)号：US11730711B2

公开(公告)日：2023-08-22

申请号：US17175111

申请日：2021-02-12

申请人： SOCIÉTÉ DES PRODUITS NESTLÉ S.A. ,  BAYLOR COLLEGE OF MEDICINE

发明人： Stephen Kirnon ,  Eric Freedland ,  Rajagopal V. Sekhar

IPC分类号： A61K31/198 ,  A61K38/05 ,  A61K31/167 ,  A61K31/223 ,  A61K31/341 ,  A61K38/21 ,  A61K31/683 ,  A61K31/27 ,  A61K45/06 ,  A61K31/381 ,  A61K31/205 ,  A23K20/142 ,  A23K50/50 ,  A61P21/00 ,  A61P39/00 ,  A61P31/18 ,  A61P29/00 ,  A61K38/02

CPC分类号： A61K31/198 ,  A23K20/142 ,  A23K50/50 ,  A61K31/167 ,  A61K31/205 ,  A61K31/223 ,  A61K31/27 ,  A61K31/341 ,  A61K31/381 ,  A61K31/683 ,  A61K38/02 ,  A61K38/05 ,  A61K38/21 ,  A61K45/06 ,  A61P21/00 ,  A61P29/00 ,  A61P31/18 ,  A61P39/00 ,  A61K31/198 ,  A61K2300/00 ,  A61K31/167 ,  A61K2300/00 ,  A61K31/27 ,  A61K2300/00 ,  A61K31/205 ,  A61K2300/00 ,  A61K31/223 ,  A61K2300/00 ,  A61K31/381 ,  A61K2300/00 ,  A61K31/341 ,  A61K2300/00 ,  A61K31/683 ,  A61K2300/00 ,  A61K38/21 ,  A61K2300/00

摘要： Compositions and methods are related to utilizing glycine and N-acetylcysteine for a variety of medical conditions related to reduced levels of glycine, N-acetylcysteine, and/or glutathione, for example, muscle loss such as sarcopenia, HIV infection and other infections, organ damage such as those from diabetes and insulin resistance and diabetic nephropathy, cardiac function and failure such as preventing or improving heart failure, fatty liver, cancer prevention, and other conditions.

公开(公告)号：US20230055117A1

公开(公告)日：2023-02-23

申请号：US17893840

申请日：2022-08-23

申请人： Genome And Company ,  Lactomason Co., Ltd.

发明人： Han Soo Park

IPC分类号： C12N1/20 ,  A23K50/50 ,  A23K10/18 ,  A23L33/135 ,  A61P1/16 ,  A61P9/00 ,  A61P3/06 ,  A61P3/10 ,  A61P29/00 ,  A61K35/747

摘要： The present invention relates to a novel strain of Lactobacillus fermentum LM1016 deposited with the Korean Culture Center of Microorganisms under accession number KCCM12468P. The novel strain of the present invention has an effect of treating or preventing cardiovascular diseases, obesity, fatty liver or diabetes mellitus.
The present invention relates to a composition comprising the strain, and the composition may be used in a pharmaceutical product, a health functional food, a dairy product, a fermented product, a food additive and an animal feed and the like.

公开(公告)号：US11576403B2

公开(公告)日：2023-02-14

申请号：US16705875

申请日：2019-12-06

申请人： Société des Produits Nestlé S.A.

发明人： Yuanlong Pan ,  Hui Xu

IPC分类号： A23K50/40 ,  A23K10/30 ,  A23K20/163 ,  A23K10/20 ,  A23K50/20 ,  A23K50/50 ,  A23K50/70

摘要： The invention provides compositions and methods for metabolic health in an animal comprising administering a non-ketogenic composition to the animal, wherein the non-ketogenic composition comprises about 5% to about 25% carbohydrates, about 30% to about 60% protein, and about 10% to about 40% fat. Additionally, the composition can have a protein to carbohydrate ratio of at least 2:1.

公开(公告)号：US11419811B2

公开(公告)日：2022-08-23

申请号：US16580658

申请日：2019-09-24

申请人： BASF SE

发明人： Bruno Kaesler ,  Rolf Knöll ,  Mewes Boettner ,  Eckhard Budde ,  Christine Lang ,  Martin Ryser ,  Markus Veen

IPC分类号： A61K8/99 ,  A23G4/12 ,  A61Q11/00 ,  C12N1/20 ,  A23L33/135 ,  A23G3/36 ,  A61K35/747 ,  A23K50/10 ,  A23K50/30 ,  A23K50/40 ,  A23K50/50 ,  A23K50/70 ,  A23K50/75 ,  A23K50/80 ,  A23L7/10 ,  A61K8/02 ,  A61K8/04 ,  A61K8/60 ,  C12R1/225

摘要： The present invention relates to a microorganism belonging to the group of lactic acid bacteria characterized in that it is capable of specifically binding to Streptococcus mutans, wherein the specific binding is (i) resistant to heat treatment; and/or (ii) resistant to protease treatment; and/or (iii) calcium-dependent; and/or (iv) formed within a pH range between 4.5 and 8.5; and/or (v) formed in the presence of saliva. Preferably, the specific binding can be assayed as follows: (a) growing said microorganism to stationary phase; (b) mixing said microorganism with Streptococcus mutans which has been grown to stationary phase; (c) incubating the mixture obtained in step (b) under conditions allowing the formation of aggregates of said microorganism and Streptococcus mutans and (d) detecting aggregates by the occurrence of a pellet. Another aspect of the present invention is an analog or fragment of said microorganism which is thermally inactivated or lyophilized, wherein said analog or fragment retains the capability of specifically binding to Streptococcus mutans. In addition, the present invention encompasses compositions and additives for food, feed or drinks comprising the microorganism belonging to the group of lactic acid bacteria which specifically bind to Streptococcus mutans or an analog or fragment thereof. Moreover, uses of said microorganism or said analog or fragment thereof for the preparation of an anticariogenic or pharmaceutical composition or anticariogenic food or feedstuff as well as methods for producing said compositions or food or feedstuff are provided by the present invention.

公开(公告)号：US20220220001A1

公开(公告)日：2022-07-14

申请号：US17709809

申请日：2022-03-31

申请人： Imam Abdulrahman Bin Faisal University

发明人： Faiza QURESHI ,  Muhammad NAWAZ

IPC分类号： C01G9/02 ,  B01J35/00 ,  B01J35/08 ,  B01J35/10 ,  B01J20/06 ,  B01J20/28 ,  A61P35/00 ,  A61K33/30 ,  A61K9/14 ,  C02F1/72 ,  C02F1/28 ,  A23K20/20 ,  A23L33/16 ,  C02F1/32 ,  C02F1/30 ,  B01J23/06 ,  A23K50/40 ,  C02F1/00 ,  A23K50/20 ,  A23K50/10 ,  A23K50/50 ,  B01J37/03 ,  B01J37/00

摘要： A method of using ZnO particles for the treatment of colon cancer and a method of using the particles for reducing the concentration of an organic contaminant in an aqueous solution is described. The ZnO particles are substantially spherical and may have nanopetals that provide a nanoflower morphology. The synthesis and characterization of the ZnO particles is also discussed.

公开(公告)号：US11325839B2

公开(公告)日：2022-05-10

申请号：US15868418

申请日：2018-01-11

申请人： Imam Abdulrahman Bin Faisal University

发明人： Faiza Qureshi ,  Muhammad Nawaz

IPC分类号： A61K33/30 ,  A61P35/00 ,  C01G9/02 ,  B01J35/00 ,  B01J35/08 ,  B01J35/10 ,  B01J20/06 ,  B01J20/28 ,  A61K9/14 ,  C02F1/72 ,  C02F1/28 ,  A23K20/20 ,  A23L33/16 ,  C02F1/32 ,  C02F1/30 ,  B01J23/06 ,  A23K50/40 ,  C02F1/00 ,  A23K50/20 ,  A23K50/10 ,  A23K50/50 ,  B01J37/03 ,  B01J37/00 ,  C02F101/30

摘要： A method of using ZnO particles for the treatment of colon cancer and a method of using the particles for reducing the concentration of an organic contaminant in an aqueous solution is described. The ZnO particles are substantially spherical and may have nanopetals that provide a nanoflower morphology. The synthesis and characterization of the ZnO particles is also discussed.

公开(公告)号：US20220118037A1

公开(公告)日：2022-04-21

申请号：US17499261

申请日：2021-10-12

申请人： GRAPE KING BIO LTD

发明人： Chin-Chu CHEN ,  I-Chen LI ,  Tsung-Ju LI ,  Ting-Yu LU ,  Yen-Po CHEN

IPC分类号： A61K36/07 ,  A61P21/06 ,  B01D11/02 ,  A23L33/10 ,  A23L31/00 ,  A23K50/50

摘要： The invention provides a method for improving sarcopenia of a subject in need thereof by using Phellinus linteus, in which the method includes administering an effective dose of composition to the subject, and the composition includes Phellinus linteus (NITE BP-03321 and BCRC 930210) as an effective substance. By using the aforementioned composition including an extract of a fermented product of the Phellinus linteus and/or its derivative, diameters of myotubes, amounts of muscles and muscle muscular endurance can be maintained, thereby improving sarcopenia.